Abstract
Microglial activation is one of the causative factors of neuroinflammation in cerebral ischemia. Activation via Toll-like receptors (TLRs) causes increased proinflammatory cytokine expression, such as interleukin-23 (IL-23) and interleukin-17 (IL-17), leading to inflammatory immune responses and neuronal damage. In this study, using a rat focal cerebral ischemia reperfusion (IR) model and an in vitro oxygen-glucose deprivation reperfusion (OGDR) system, we found that TLR2, IL-23 and IL-17 form an axis that leads to increased neuronal apoptosis. TLR2 activation results in IL-23 production which stimulates IL-17 production by microglia. This microglial axis may be a potential therapeutic target to control neuroinflammation in brain IR.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis / physiology
-
Blotting, Western
-
Brain Ischemia / immunology
-
Brain Ischemia / metabolism*
-
Brain Ischemia / pathology
-
Cells, Cultured
-
Enzyme-Linked Immunosorbent Assay
-
Immunohistochemistry
-
In Situ Nick-End Labeling
-
Inflammation / immunology
-
Inflammation / metabolism*
-
Inflammation / pathology
-
Interleukin-17 / metabolism*
-
Interleukin-23 / metabolism*
-
Male
-
Microglia / immunology
-
Microglia / metabolism*
-
Neurons / pathology
-
RNA, Small Interfering
-
Rats
-
Rats, Sprague-Dawley
-
Reperfusion Injury / immunology
-
Reperfusion Injury / metabolism
-
Reperfusion Injury / pathology
-
Signal Transduction / physiology
-
Toll-Like Receptor 2 / metabolism*
-
Transfection
Substances
-
Interleukin-17
-
Interleukin-23
-
RNA, Small Interfering
-
Tlr2 protein, rat
-
Toll-Like Receptor 2